{"id":40899,"date":"2021-10-07T15:38:49","date_gmt":"2021-10-07T22:38:49","guid":{"rendered":"https:\/\/lapost.us\/?p=40899"},"modified":"2021-10-07T15:38:49","modified_gmt":"2021-10-07T22:38:49","slug":"pfizer-applies-for-covid-19-vaccine-authorization-in-children-5-11","status":"publish","type":"post","link":"https:\/\/lapost.us\/?p=40899","title":{"rendered":"Pfizer applies for COVID-19 vaccine authorization in children 5-11"},"content":{"rendered":"<p>There\u2019s a potential light at the end of the tunnel for parents worried about their children under 12.<\/p>\n<p>Pfizer said Thursday that it had submitted an application to the Food and Drug Administration (FDA) for emergency use authorization of its COVID-19 vaccine in children ages 5 to 11.<\/p>\n<p>The application has been highly anticipated, as millions of parents are eager to vaccinate their kids. No vaccine is currently available for children under 12.<\/p>\n<p>The FDA has previously said it would move quickly to review the application, &#8220;likely in a matter of weeks rather than months.\u201d<\/p>\n<p>An FDA advisory committee is meeting to discuss the application on Oct. 26, and the agency will decide whether to accept the recommendation. A Centers for Disease Control and Prevention panel will meet shortly after.<\/p>\n<p>Children generally do not get severely ill with COVID-19 as much as older people do, but there were still almost 175,000 cases among children in the week ending Sept. 30, according to the American Academy of Pediatrics (AAP).<\/p>\n<p>Between 0.1 percent and 1.9 percent of COVID-19 cases in children resulted in hospitalization, according to AAP.<\/p>\n<p>Pfizer has tested a dose for children that is one-third the amount used in adults. Late last month, it announced positive results from its studies, pointing to a \u201cfavorable safety profile and robust neutralizing antibody responses.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>There\u2019s a potential light at the&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-40899","post","type-post","status-publish","format-standard","hentry","category-u-s-a"],"_links":{"self":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/40899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40899"}],"version-history":[{"count":1,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/40899\/revisions"}],"predecessor-version":[{"id":40900,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/40899\/revisions\/40900"}],"wp:attachment":[{"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}